We are live on
!
Find out more
CTC
Central Trust Company Portfolio holdings
AUM
$5.53B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+2.97%
1 Year Est. Return
+28.94%
3 Year Est. Return
+83.96%
5 Year Est. Return
+104.85%
10 Year Est. Return
+351.46%
AUM
$1.45B
AUM Growth
+$80.7M
(+5.9%)
Cap. Flow
+$52.9M
Cap. Flow
% of AUM
3.65%
Top 10 Holdings %
Top 10 Hldgs %
20.47%
Holding
1,274
New
111
Increased
290
Reduced
384
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Gold Trust
IAU
|
+$11.8M |
| 2 |
Great Southern Bancorp
GSBC
|
+$8.94M |
| 3 |
Sprott Physical Gold and Silver Trust
CEF
|
+$6.25M |
| 4 |
PepsiCo
PEP
|
+$4.07M |
| 5 |
O'Reilly Automotive
ORLY
|
+$4.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$4.37M |
| 2 |
Medtronic
MDT
|
+$2.83M |
| 3 |
CVS Health
CVS
|
+$2.33M |
| 4 |
Newell Brands
NWL
|
+$1.75M |
| 5 |
Alibaba
BABA
|
+$1.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 14.91% |
| 2 | Industrials | 12.55% |
| 3 | Healthcare | 12.2% |
| 4 | Consumer Staples | 12.15% |
| 5 | Technology | 11.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Ligand Pharmaceuticals
LGND
$5.75B
| $45K | ﹤0.01% |
713
-95
| -12% | -$6K |
|
|
NUVA
702
DELISTED
NuVasive, Inc.
NUVA
| $45K | ﹤0.01% |
672
-105
| -14% | -$6.77K |
|
703
AMN Healthcare
AMN
$1.31B
| $44K | ﹤0.01% |
1,155
-207
| -15% | -$7.07K |
|
704
Watsco Inc
WSO
$13.1B
| $44K | ﹤0.01% |
300
| – | – |
|
|
GIMO
705
DELISTED
Gigamon Inc.
GIMO
| $44K | ﹤0.01% |
975
-145
| -13% | -$7.55K |
|
|
LLTC
706
DELISTED
Linear Technology Corp
LLTC
| $44K | ﹤0.01% |
700
| – | – |
|
707
AerCap
AER
$22.7B
| $43K | ﹤0.01% |
1,030
-80
| -7% | -$3.37K |
|
|
EFOR
708
Everforth Inc
EFOR
$1.27B
| $43K | ﹤0.01% |
979
-148
| -13% | -$5.88K |
|
709
Copart
CPRT
$30.3B
| $43K | ﹤0.01% |
6,240
+5,440
| +680% | +$37K |
|
710
Donaldson
DCI
$10.6B
| $43K | ﹤0.01% |
1,010
| – | – |
|
711
Mueller Water Products
MWA
$3.74B
| $43K | ﹤0.01% |
3,264
-626
| -16% | -$8.03K |
|
712
Vanguard FTSE Europe ETF
VGK
$31B
| $43K | ﹤0.01% |
900
| – | – |
|
713
Xylem
XYL
$25.4B
| $43K | ﹤0.01% |
865
| – | – |
|
|
CYS
714
DELISTED
CYS Investments Inc.
CYS
| $43K | ﹤0.01% |
5,554
-112
| -2% | -$913 |
|
715
Apogee Enterprises
APOG
$811M
| $42K | ﹤0.01% |
783
-123
| -14% | -$5.7K |
|
716
Lumen
LUMN
$6.89B
| $42K | ﹤0.01% |
1,762
-203
| -10% | -$5.15K |
|
717
Martin Marietta Materials
MLM
$36.6B
| $42K | ﹤0.01% |
190
| – | – |
|
718
Pricesmart
PSMT
$5.32B
| $42K | ﹤0.01% |
500
| – | – |
|
|
SNCR
719
DELISTED
Synchronoss Technologies
SNCR
| $42K | ﹤0.01% |
122
-13
| -10% | -$4.89K |
|
720
Targa Resources
TRGP
$63.3B
| $42K | ﹤0.01% |
752
-321
| -30% | -$16.2K |
|
|
NTUS
721
DELISTED
Natus Medical Inc
NTUS
| $42K | ﹤0.01% |
1,203
-161
| -12% | -$6.32K |
|
|
LNCE
722
DELISTED
Snyders-Lance, Inc.
LNCE
| $42K | ﹤0.01% |
+1,091
| New | +$39.9K |
|
723
Casey's General Stores
CASY
$27.2B
| $41K | ﹤0.01% |
349
-50
| -13% | -$5.95K |
|
724
Chesapeake Utilities
CPK
$3.21B
| $41K | ﹤0.01% |
612
-44
| -7% | -$2.81K |
|
|
SF
725
Stifel
SF
$12.2B
| $41K | ﹤0.01% |
1,856
| – | – |
|
Similar funds
GAM
BCL
IA
AFI
MC
SEIA
VAM
GCM
Central Trust Company's Q4 2016 Portfolio in Review
As of Q4 2016, Central Trust Company held 1,274 positions worth $1.45B, up 5.9% from $1.37B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Central Trust Company deployed $52.9M of net new capital in Q4 2016, opening 111 new positions and adding to 290 existing holdings. Its largest new stake was PARSLEY ENERGY INC: 57,050 shares worth $2.01M.
By sector, the portfolio is most concentrated in Miscellaneous at 15% of assets, up from 15% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Allergan plc, an estimated $4.37M trimmed.
- Central Trust Company's largest Q4 2016 buy was PARSLEY ENERGY INC: 57,050 shares worth $2.01M.
- Central Trust Company added most to iShares Gold Trust in Q4 2016, an estimated $11.8M increase.
- Central Trust Company's biggest Q4 2016 reduction was Allergan plc, cutting an estimated $4.37M.
- Central Trust Company fully exited VEOLIA ENVIRONNEMENT in Q4 2016, selling an estimated $329K.
- Central Trust Company's ten largest holdings make up 20% of its $1.45B portfolio in Q4 2016.
- Central Trust Company opened 111 new positions and closed 58 in Q4 2016.
- Central Trust Company's portfolio value rose 5.9% quarter-over-quarter to $1.45B.
Based on Central Trust Company's 13F filing for Q4 2016, filed 24 Jan 2017.